Novo reported 1.3 million prescriptions for its weight-loss pill, which is now available in the U.S., in the first quarter of ...

Novo Nordisk is seeing brisk early demand for its new weight-loss pill as competition with ​U.S. rival Eli Lilly intensifies.

GLP-1 shots and pills both help regulate appetite and blood sugar. Learn the differences in effectiveness, cost, and who ...

Americans starting weight-loss medicines for the first time want lower cost and greater convenience as they consider pills from Novo Nordisk NOVOb.CO or Eli Lilly LLY.N, according to seven doctors who ...

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

Popular weight-loss drug Wegovy is now available in pill form in the United States. Novo Nordisk, the Danish drugmaker behind Wegovy and the GLP-1 drug Ozempic, announced on Monday that the starting ...

The U.S. Food and Drug Administration on Wednesday approved a second oral GLP-1 medication, giving adults eligible for weight loss medication another option. The new pill, called Foundayo, is made by ...

By Stine Jacobsen and Maggie Fick COPENHAGEN/LONDON, May 6 (Reuters) - Novo Nordisk beat first-quarter profit forecasts and ...

Federal regulators on Wednesday approved Eli Lilly’s new weight-loss pill, a second daily oral medication to treat obesity and other weight-related conditions. The Food and Drug Administration granted ...

April 1 (Reuters) - The U.S. FDA on Wednesday approved Eli Lilly's weight-loss pill, setting up its next battle with rival Novo Nordisk for the millions of Americans seeking highly effective GLP-1 ...